Cargando…
miR-9-5p Mediates ABCC1 to Elevate the Sensitivity of Glioma Cells to Temozolomide
Chemotherapy combined with surgery is an important clinical treatment for glioma, but endogenous or acquired temozolomide (TMZ) resistance can lead to poor prognosis. microRNA (miR)-9-5p acts in biological function of glioma, but the drug resistance of miR-9-5p in glioma is under exploration. The st...
Autores principales: | Chen, Xiang-Rui, Zhang, Yan-Guo, Wang, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438306/ https://www.ncbi.nlm.nih.gov/pubmed/34532283 http://dx.doi.org/10.3389/fonc.2021.661653 |
Ejemplares similares
-
MiR-136 modulates glioma cell sensitivity to temozolomide by targeting astrocyte elevated gene-1
por: Wu, Hao, et al.
Publicado: (2014) -
HOXA13, Negatively Regulated by miR-139-5p, Decreases the Sensitivity of Gastric Cancer to 5-Fluorouracil Possibly by Targeting ABCC4
por: Chen, Zhengqian, et al.
Publicado: (2021) -
miR-1297 sensitizes glioma cells to temozolomide (TMZ) treatment through targeting adrenomedullin (ADM)
por: He, Zongze, et al.
Publicado: (2022) -
miR‐152‐5p suppresses glioma progression and tumorigenesis and potentiates temozolomide sensitivity by targeting FBXL7
por: Kong, Shiqi, et al.
Publicado: (2020) -
A Novel miR-98 Negatively Regulates the Resistance of Endometrial Cancer Cells to Paclitaxel by Suppressing ABCC10/MRP-7
por: Huang, Wei, et al.
Publicado: (2021)